AMP expands into Parkinson's

NIH's Accelerating Medicines Partnership (AMP), a public-private partnership focused on identifying and validating new disease targets and biomarkers, announced a five-year, $24 million expansion into Parkinson's disease that builds on a

Read the full 318 word article

User Sign In